BU-NOT-SET

CONTACT US
The power of analytics and AI in the era of continuous RNA manufacturing
  • Biologics
people in a lab
Insight
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
  • Biologics
person in lab
Insight
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
  • Biologics
mRNA
Insight
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
  • Biologics
vaccine in bottles
Insight
Choosing the optimal container format for sterile drug products
  • Drug product
  • Manufacturing
Containers for sterile drug products
Insight
FDA inspection success at Recipharm’s site in Bengaluru, India
  • Manufacturing
Two people looking at a printed document
Insight
Lyophilisation Services
  • Drug product
  • Manufacturing
bottles
Fact sheet
Using blow-fill-seal technology for biologic and vaccine delivery
  • Drug product
  • Manufacturing
blow-fill-seal
Insight
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
vials
Webinar
Insight
  • Manufacturing
Is outsourcing the most viable pathway for innovators?
Case study
  • Drug product
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
Insight
  • Industry trends
Recipharm Wins two 2020 CMO Leadership Awards
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list
Insight
  • Drug substance
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
Insight
  • Industry trends
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19